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The primary purpose of the present study was to expand our understanding of the impact of light exposures on the endocrine
and autonomic systems as measured by acute cortisol, alpha amylase, and melatonin responses. We utilized exposures from
narrowband long-wavelength (red) and from narrow-band short-wavelength (blue) lights to more precisely understand the role
of the suprachiasmatic nuclei (SCN) in these responses. In a within-subjects experimental design, twelve subjects periodically
received one-hour corneal exposures of 40 lux from the blue or from the red lights while continuously awake for 27 hours. Results
showed-that, as expected, only the blue light reduced nocturnal melatonin. In contrast, both blue and red lights aﬀected cortisol
levels and, although less clear, alpha amylase levels as well. The present data bring into question whether the nonvisual pathway
mediating nocturnal melatonin suppression is the same as that mediating other responses to light exhibited by the endocrine and
the autonomic nervous systems.
1.Introduction
Circadian rhythms repeat every 24 hours (circa = approx-
imately; die = day), reﬂecting the coupling of the self-
oscillating endogenous master clock in the suprachiasmatic
nuclei (SCN) with the natural 24-hour light-dark cycle.
Perhaps the best known circadian rhythm is the synthesis
pattern of the hormone melatonin by the pineal gland
in the brain [1, 2]. The SCN closely regulate melatonin
synthesis; melatonin concentrations, measured in plasma
or saliva, are high during the night and low during the
day. Melatonin is often called the “hormone of darkness”
because its peak concentration levels are closely tied to the
middle of the night in both nocturnal and diurnal animals. If
lightofsuﬃcientirradiance,appropriatewavelengthsandfor
suﬃcientdurationispresentedtotheretinaduringthenight,
melatonin synthesis will be curtailed in a dose dependent
manner [3].
Glucocorticoid hormones, of which cortisol is the most
importantoneinhumans,aresteroidhormonesproducedby
the adrenal cortex and participate in the body’s homeostasis
and stress responses [4–6]. Cortisol concentrations also
followacircadianrhythm[7]althoughonethatisapparently
more complex than the melatonin rhythm. Unlike the
melatonin rhythm, human cortisol rhythms do not seem
to be associated with day and night per se but seem to
be more closely tied to the transition periods from dark
to light and, to a lesser extent, from light to dark. In
additiontoitscircadianrhythmexhibitingapredictablepeak
in the morning, cortisol levels typically elevate sharply in
the morning, 30 minutes to an hour after awakening. The
o p p o s i t ea p p e a r st r u ef o rn o c t u r n a ls p e c i e s ,s u c ha sr a t s
[8, 9], in that they exhibit a maximum corticosterone level
and a sharp increase in its production in the evening with a
broad nadir during the end of the night. Like humans then,
the peak and spike in corticosterone amplitude in nocturnal
animals are associated with the start of the daily activity
period [10].
The glucocorticoid levels synthesized by the adrenal
gland across the 24-hour day appear to be under the control
of two distinct systems, one governed by the hypothalamic-
pituitary-adrenal (HPA) axis [5] and one controlled by
the autonomic nervous system through the adrenal medula
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by the pituitary gland, the central part of the HPA axis,
has traditionally been considered necessary for cortisol
production and, indeed, under normal conditions ACTH
levels follow a similar circadian pattern as cortisol [13, 14].
Although the average ACTH levels vary with circadian time,
the momentary levels in a particular individual exhibit
pulsatile spikes as, in fact, do cortisol levels [14]. These
pulsatile spikes in ACTH occur throughout the 24-hour
day, but interestingly cortisol spikes are much less frequent
at night and do not appear to be systematically related to
the sharp peak in cortisol associated with awakening [15].
Further evidence supports the conclusion that ACTH and
glucocorticoid production can be decoupled [16]. Ablation
of the SCN eliminates the ACTH circadian rhythm but
not necessarily the production of corticosterone [11, 17].
Further, in rats, retinal stimulation by light during the night
will modulate corticosterone production without aﬀecting
ACTH [11]. It has also been shown that this acute response
tolightatnightismediatedbytheSCN,possiblythroughthe
autonomicnervoussystem(sympatheticsystem)innervating
the adrenal medulla [11, 18]. In one study, ablation of the
SCNor thesplanchnicnerveinnervatingtheadrenalmedulla
eliminated the corticosterone response to light at night in
rats [11]. Clearly then, the SCN seem to be tied to both the
HPA and to the autonomic nervous systems as they aﬀect
glucocorticoid production.
Salivaryalphaamylaseisanenzymethathasbeenusedas
a marker for the sympathetic nervous system response [19–
22] and, like cortisol, has been shown to respond to psy-
chosocial stress [19]. As with melatonin and cortisol, salivary
alphaamylaseproductionexhibitsaregularcircadianpattern
[20]. During normal working schedules, salivary alpha
amylase production roughly mirrors cortisol production
across the 24-hour day [19]. In other words, under normal,
steady-state conditions, high levels of cortisol tend to be
associated with low levels of alpha amylase and vice versa.
Interestingly, even the transient, awakening morning cortisol
peak in humans is mirrored by a sharp, morning trough of
alphaamylaseconcentration[23].Itisgenerallybelievedthat
the HPA and the sympathetic systems buﬀer one another
as a negative feedback loop to minimize large swings in the
organism’s physiology when it is suddenly threatened [6], as
exempliﬁed by their approximately counterphased circadian
rhythms and acute response to awakening in the morning.
Only under signiﬁcant and maintained environmental strain
do the two systems respond similarly [20, 23], producing a
positive feedback loop that incapacitates the organism (e.g.,
fainting)ormovesittoactiontoeliminatetheenvironmental
threat [4]. When environmental strain persists, particularly
without eﬀective action by the organism, this positive
feedback loop can have serious negative consequences to the
organism’s well-being [4].
Although many of the details regarding the role of the
SCN in modulating the circadian, endocrine, and autonomic
nervous systems’ responses (melatonin, cortisol, and alpha
amylase) remain unresolved, it appears very clear that the
SCN aﬀect the responses from these systems. Since light is
a well-known stimulus for suppressing the synthesis of the
hormone melatonin at night, it was considered important
for the present study to also better understand how light
might aﬀect cortisol, another endocrine hormone, and alpha
amylase, a marker of the sympathetic system. For example,
previous studies have shown that exposure to high levels of
polychromatic(white)light(800lux[lx]atthecornea)inthe
morning, but not in the evening, increased cortisol levels in
humans [24, 25]. Studies have also shown that morning light
can increase heart rate, suggesting an impact of light on the
autonomic nervous system [26].
The general purposes of the present study then were,
ﬁrst, to obtain simultaneous baseline measurements of three
biomarkers, melatonin, cortisol, and alpha amylase, in the
absence of light, to more closely examine the relation-
ships between these three circadian rhythms during sleep
restriction and in that context to, second, expand our
understandingoftheimpactofacutelightexposuresonthese
biomarkersduring thedayandduring thenight.With regard
to the second purpose, we utilized two lighting conditions,
one-hour exposures of 40lx each from a narrowband, short-
wavelength (blue) and from a narrowband, long-wavelength
(red) light, to more precisely understand the involvement of
the SCN in the endocrine and autonomic nervous systems’
responses to light during the day and during the night.
2.MaterialsandMethods
The present study was conducted in accordance with the
Declaration of Helsinki (1964) and was approved by Rens-
selaer Polytechnic Institute’s Institute Review Board (IRB).
2.1. Subject Selection. Twelve of sixteen subjects recruited
fromRensselaerPolytechnicInstituteinTroy,N.Ycompleted
the repeated-measures study, and their data are reported
here. Eight male subjects (ages = 20–40 years) and four
female subjects (ages = 19–53 years) completed the study.
Althoughthesubjectpool representsawideagerangeandan
unbalanced gender distribution, there is no reason to believe
these factors confound the results because all subjects saw
every condition in the within-subjects experimental design.
Furthermore, there is little evidence that either age (for
the range in our subject pool) or gender are systematically
related to the amplitude or phase of melatonin, cortisol, or
alpha amylase synthesis [22, 27, 28]. Subjects were screened
for major health problems (heart disease, diabetes, asthma,
and high blood pressure) by a research nurse via a phone
interview and, except for two women taking oral contra-
ceptives, for pharmaceuticals (including adrenergic agonists
and antagonists). Subjects were also not allowed to take any
nonsteroid anti-inﬂammatory medication starting 72 hours
prior to the study. All subjects were nonsmokers and were
asked to not consume alcohol or caﬀeine starting 12 hours
prior to the start of the experiment. Subjects were asked
to keep a regular schedule on the week of the experiment
and report if there were any deviation from their normal
schedule. If so, the subject was rescheduled to participate
in the experiment on another Friday evening. None of the
subjects had traveled more than three time zones in the
monthprior tothestudy. Afewdaysprior totheexperiment,
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Chronotype Questionnaire (MCTQ) for the experiment
[29]. The MCTQ data were used as assurance that subjects
were not extremely early or extremely late chronotypes. All
subjects reported having a chronotype between “moderately
early” and “moderately late.” Moreover, all subjects reported
having bed times no later than 23:00 and wake up times
no later than 08:00 on weekdays and bed times no later
than 00:00 and wake-up times no later than 09:00 on free
days. The regular schedules increased the likelihood that
all subjects were normal and homogenous with respect to
circadian phase.
2.2. Lighting Conditions. Subjects were individually exposed
for one hour to two experimental lighting conditions, two
spectra (blue, B and red, R), both at one level (40lx). For
the third lighting condition, serving as the control condition,
subjects sat quietly in a dim room (<3lux at the eye and
referred hereafter as dark, D). For the B and R lighting
conditions subjects were individually positioned in a chin
rest in front of a 0.6 × 0.6 × 0.6m light box; each box
was ﬁtted with either an array of red or of blue light-
emitting diodes (LEDs). The LED arrays (LXHL-MB1D
(Lumileds, Luxeon I, blue [nominal 470nm], Lambertian,
1W, 350mA and LXHL-MD1D (Lumileds, Luxeon I, red
[nominal 625nm], Lambertian, 1W, 350mA.)) were located
behind the front box apertures to be outside the subject’s
direct view, thereby creating a uniform, nonglaring dis-
tribution of light within the box. The spectral emissions
of the blue LEDs peaked at 470nm with a full width at
half maximum (FWHM) of 25nm. Light from the red
LEDs peaked at 625nm with a FWHM of 25nm. Before
the experiment, each of the light boxes was calibrated
using a Gigahertz illuminance photometer to provide the
prescribed corneal illuminance levels when subjects were
positioned in the chinrest. The spectral radiances of the
red and blue lighting conditions were measured prior to
the experiment with a calibrated spectroradiometer (Pho-
toResearch, model PR705a) and diﬀuse white reﬂectance
standard (Labsphere, model SR 099); these were used to
calibrate the Gigahertz illuminance readings during the
experiment. Two boxes provided blue light (40μW/cm2 at
40lx), and two emitted red light (19μW/cm2 at 40lx) in
the plane of the subjects’ corneas; light levels could be
adjusted with an electronic dimmer to reach the prescribed
light levels without signiﬁcantly aﬀecting the relative spectral
distributions of the LED emissions. Measurements of pupil
area (average ± standard deviation) completed after the
experiment with a diﬀerent group of subjects (n = 5)
were red at 40lx, 23 ± 11mm2 and blue at 40lx, 6.6 ±
1.4mm 2.
The speciﬁc illuminance value of 40 lx was chosen
because this value has been shown in previous studies to
increase nocturnal alertness after a one-hour exposure [30]
and is above threshold and below saturation for melatonin
suppression, as described by Rea and colleagues [3]. The
light level used in the red light box was selected to have
the same photopic illuminance as the blue light, thus
providing approximately equal visual stimulation without
causing nocturnal melatonin suppression.
2.3. Procedures. Figure 1 shows the course of the 27-hour
experiment that employed seven sample times for the
baseline biomarker measurements (open arrows) and seven
sample times for the lighting condition measurements (ﬁlled
arrows). Subjects were assigned to one of three sessions, red,
blue, or dark, according to a prescribed schedule designed
to counterbalance exposures to the three lighting conditions
across subjects. Subjects started each session at 07:00 (always
on Fridays) to 10:00 the following day at least one week
apart. The experiment ran from March 2008 to March
2009.
One hour prior to making the baseline measurements
until completion of the lighting condition measurements
(2 hour duration) subjects sat quietly without talking,
reading, or otherwise interacting with their environment;
these periods were designated quite times (QT), illustrated
in Figure 1. All other times were designated as free times
(FT)whensubjectsweregivenscheduledmealsortheycould
drink noncaﬀeinated nourishment, talk with each other, or
interact with their laptop computers while they sat in the
dim (<3lx of light at the eye) laboratory. If subjects used
their computers, they were required to cover the display
with an orange ﬁlter supplied by an experimenter having a
transmittance of less than 2% from 380 to 550nm. Displays
were also dimmed to the minimum brightness.
At all times during a 27-hour session, subjects remained
sitting except when they needed to use the restrooms
adjacent to the laboratory. They were permitted to use
the restroom only during FTs; while absent from the
laboratory for this purpose, they were required to wear dark
sunglassesenhancedwithneutraldensityﬁlters(lessthan5%
transmittance).TenminutesbeforetheendofanFT,subjects
wereaskedtobrushtheirteethusingdisposabletoothbrushes
provided to them while, again, wearing the enhanced
sunglasses. They were asked not to use toothpaste so that
there would be less chance of saliva sample contamination.
The data collection times for the baseline measurements
were at 08:00, 12:00, 16:00, 20:00, 00:00, 04:00, and at
08:00 the following day. Lighting condition measurements
were taken approximately one hour after each baseline
measurement and always following a one-hour exposure to
40lx of the blue (B) or to 40lx of the red (R) lights or while
continuing to sit quietly in the dark (D). Experimenters in
the room continuously assured that subjects remained awake
with their eyes open throughout the entire session, and they
were still more carefullymonitored during the light exposure
periods to ensure compliance with the protocol.
2.4. Saliva Collection and Analysis. Saliva samples were col-
lected using the Salivette system from Alpco Diagnostics.
This system consists of a centrifuge vessel with a suspended
insert in which a cotton swab is placed. To collect the saliva,
the cap was removed, and subjects put the tube against their
lips and took the cotton swab into their mouths without
touching it with their hands. The subjects then chewed the
swab to impregnate it with saliva. Between 1-2ml of saliva
was required for the analyses. After chewing the cotton, they
then spit the cotton back into the suspended insert, and
the cap on the tube was replaced. The vessels containing4 International Journal of Endocrinology
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Figure 1: Study protocol. Seven equally spaced baseline measurements were always taken after three hours in the dark (open arrows), except
for the ﬁrst baseline measurement that was taken after one hour in the dark. Subjects were assigned to one of three sessions (red, blue, and
dark) corresponding to one of the three lighting conditions they would experience during that session (R, B, and D). Except for the last one,
lighting condition measurements were taken one hour after and three hours before each baseline measurements.
the suspended saliva-impregnated cotton swabs were then
spun in a centrifuge at 1000×g for ﬁve minutes, causing
the saliva to collect at the bottom of the centrifuge vessel.
Saliva samples were frozen for transport to a laboratory for
melatonin, cortisol, and alpha amylase assays (Salimetrics,
LLC, State College, PA). The sensitivity of the saliva assay
for melatonin radioimmunoassay was 0.7pg/ml, and the
intra- and interassay coeﬃcients of variability (CVs) were
12.1% and 13.2%, respectively. The limit of detection for the
cortisol assay was 0.0036μg/dl, and the intra- and interassay
CVs were 3.6% and 6.4%, respectively. The limit of detection
for the alpha amylase assay was 0.01u/ml, and the intra- and
interassay CVs were 7.2% and 5.8%, respectively.
3. Results
The analyses were divided into baseline measurements and
lighting condition measurements. Again, baseline measure-
ments were collected to examine the simultaneous circadian
variations in melatonin, cortisol, and alpha amylase produc-
tion levels for a full day of sleep restriction, and the lighting
condition measurements were collected in this context to
assess the impact of nighttime and daytime light exposures
on these three biomarkers.
3.1. Baseline Measurements. Although complete data for
cortisol and for alpha amylase were available from all 12
subjects, complete melatonin data from only seven of these
subjects were available for evaluation. Unfortunately, the
laboratory that performed the assays reported melatonin
levels greater than 50pg/ml in the saliva samples as simply
“greater than 50pg/ml.” The samples were destroyed by the
laboratory after measurement and could not be reassayed.
These inexact sample values had to be excluded from
the statistical analyses. Consequently, complete melatonin
data from just seven subjects (5 males and 2 females) are
reported here. Data for cortisol and alpha amylase are for the
12 subjects.
Data from every subject were normalized to the grand
mean of each data set, melatonin, cortisol, and alpha amy-
lase, and submitted to three sessions (corresponding to the
three lighting conditions D, R, and B) by six measurement
times (08:00, 12:00, 16:00, 20:00, 00:00, and 04:00) repeated
measures analysis of variance (ANOVA). Data collected
during the ﬁnal measurement time, 08:00 the following
day, were not included in the ANOVAs; as discussed below,
a subsequent post hoc statistical comparison was made
betweenthethreebiomarkerconcentrationsobtainedduring
the ﬁrst and the last sampling periods (i.e., at 08:00). All
three ANOVAs supported the same inferences. There was
no signiﬁcant main eﬀect of sessions, and there was no
signiﬁcant interaction between sessions and measurement
times. These ﬁnding support the inference that the baseline
measurements were independent of the lighting condition
exposures three hours prior to those baseline measurements
and that the data from all three sessions can be combined
to better characterize the simultaneous circadian variations
in melatonin, cortisol, and alpha amylase. The main eﬀect of
measurement times was highly signiﬁcant (P<. 0001) from
all three ANOVAs, suggesting that each outcome measure
followed a circadian pattern over 24 hours.
Again, these ﬁndings from the inferential statistics sup-
port the conclusion that the baseline measurements for all
three sessions were independent of the lighting condition
measurements for all three measures. Moreover, since the
twolightingconditions(BandR)hadnostatisticallyreliable,
diﬀerential eﬀects on any of the three outcome measures
relative to those obtained during the control dark (D)International Journal of Endocrinology 5
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Figure 2: Baseline measurements. Normalized concentration lev-
els of melatonin, cortisol, and alpha amylase (closed symbols)
measured under constant dark conditions while subjects were
continuouslyawakeforonedaytogetherwiththosecollectedduring
the last measurement period (open symbols) at the same clock time
as for the ﬁrst measurement period (08:00).
lighting condition, there is no reason to suppose that the
phase relationships among these biomarkers were diﬀeren-
tially aﬀected by the lighting conditions over the 27-hour
course of the study. Therefore, the curves in Figure 2 can be
taken to represent, within statistical uncertainty, the baseline
rhythms for melatonin, cortisol, and alpha amylase during
sleep restriction.
Melatonin, synthesized by the pineal, follows well-
established expectations showing maximum values in the
dark at 00:00 and 04:00, with minimum levels from 12:00
to 20:00. Cortisol levels also follow a circadian pattern
with peak levels at 08:00 and lowest levels between 20:00
and midnight. Alpha amylase levels, too, follow a clear
circadian pattern with peak levels between 12:00 and 16:00
and minimum levels at 04:00.
Thenormalizedmeansfromtheﬁnalmeasurementtime,
collected at the same clock time as the ﬁrst measurement
time (i.e., 08:00), are also shown in Figure 2. Post hoc sta-
tistical comparisons between the ﬁrst and last times of data
collection for each of the three outcome measures showed
no statistically signiﬁcant diﬀerences. Over the course of the
experiment with subjects staying awake continuously for 27
hours, melatonin, cortisol, and alpha amylase levels returned
to,orverynearto,thesamelevelsmeasuredatthestartofthe
experiment.Thisfurthersupportstheconclusion,again,that
withinstatisticaluncertaintytherewerenodiﬀerentialeﬀects
of the lighting conditions on the phase or amplitude of these
three biomarkers and, therefore, the curves in Figure 2 can
betakentorepresentsimultaneousbaselinemeasurementsof
circadian rhythms for melatonin, cortisol, and alpha amylase
during sleep restriction.
3.2. Lighting Condition Measurements. I no r d e rt od e t e rm i n e
if light had an acute eﬀect on the outcome measures over
the 27-hour protocol, each data set (melatonin, cortisol,
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Figure 3: Lighting condition measurements. Mean normalized
concentration levels of melatonin (a), cortisol (b), and alpha
amylase (c) collected during the day (09:00, 13:00, and 17:00) and
during the night (21:00, 01:00, and 05:00) following one hour
exposures of 40lx of narrowband red (R) and blue (B) lights while
subjects were continuously awake for one day, together with mean
normalized concentration levels collected at the same clock times
under constant dark (D) conditions.
and alpha amylase) collected at the end of each lighting
condition were submitted to three lighting conditions (D,
R, and B) by two times of day (day or night) by three
measurement times (ﬁrst, second, and third measurement
during the day and during the night) repeated measures
ANOVAs. Again, the three lighting condition measurement
times were one hour later and three hours before the baseline
measurement times, at 09:00, 13:00, and 17:00 during the
day and at 21:00, 01:00, and 05:00 during the night. The
times of day factor was utilized in the ANOVAs to determine
if there were measurable diﬀerences in melatonin, cortisol,
and alpha amylase between day and night. Since, however, it
was of primary interest to determine if light had diﬀerential
eﬀectsontheseoutcomemeasuresduringthedayandduring6 International Journal of Endocrinology
the night, the interaction between lighting conditions and
times of day was of more interest than the main eﬀects of
either times of day or lighting conditions; the interaction
plots for all three outcome measures are shown in Figure 3.
Data from the last of the seven measurement periods were
not included in these ANOVAs because it was a repetition of
the ﬁrst measurement time and could not be unambiguously
categorized as either day or night.
3.2.1. Melatonin. As previously described, not all of the
data could be used for the melatonin analysis. As with the
baseline data, complete data from just seven subjects are
reportedhere.ThisANOVArevealedasigniﬁcantmaineﬀect
of lighting conditions (F2,12 = 4.3; P = .04), a signiﬁcant
main eﬀect of times of day (F1,6 = 47.2; P<. 0005), and
a signiﬁcant lighting conditions by times of day interaction
(F2,12 = 5.9; P = .02).
As expected, melatonin levels were diﬀerentially higher
at night than during the day for the three lighting conditions
(i.e., therewasa signiﬁcant interaction between lighting con-
ditions and times of day). One-tail, post hoc paired student’s
t-tests showed that melatonin levels were signiﬁcantly higher
at night than during the day for all three lighting conditions
(D, R, and B), but at night melatonin levels were signiﬁcantly
lower following the blue light exposure than following both
the dark condition (P = .006) and following the red light
exposure condition (P = .004).
3.2.2. Cortisol. Data from twelve subjects were included in
the ANOVA for cortisol. There was a signiﬁcant main eﬀect
of measurement times (F2,22 = 6.4; P = .006), a signiﬁcant
lighting conditions by times of day interaction (F2,22 = 5.5;
P = .01), and a signiﬁcant times of day by measurement
times interaction (F2,22 = 38.8; P<. 001). The main eﬀect of
lighting conditions almost reached signiﬁcance (F2,22 = 3.1;
P = .07).
Based upon the signiﬁcant lighting conditions by times
of day interaction, one-tail, post hoc paired student’s t-tests
were performed. There were no signiﬁcant diﬀerences in
cortisol levels between the red and the blue lighting con-
ditions and the dark condition during the day, but cortisol
levels were signiﬁcantly lower following the dark condition
than following the blue light (P = .001) and the red light
exposures (P = .004) at night. Furthermore, there were
no signiﬁcant diﬀerences between cortisol levels recorded
duringthedayandduringthenightfollowingbothbluelight
and red light exposures; only following the dark condition
was cortisol signiﬁcantly lower at night than during the day
(P = .007). These results are consistent with the inference
that short-wavelength and long-wavelength lights do not
aﬀect cortisol levels during the day relative to darkness and
that both short-wavelength and long-wavelength lights are
capable of bringing nighttime levels of cortisol up to daytime
levels following approximately one hour of exposure.
3.2.3. Alpha Amylase. Data from twelve subjects were
included in the ANOVA for alpha amylase. A signiﬁcant
times of day main eﬀect (F1,11 = 12.0; P = .005) and
a signiﬁcant times of day by measurement times interaction
(F2,22 = 23.0; P<. 001) were found, but no signiﬁcant
lighting conditions by times of day interaction was found,
as it had been for both melatonin and cortisol. There
was, however, a suggestion from the data that light had a
diﬀerential eﬀect on alpha amylase levels. Using one-tail,
post hoc paired student’s t-tests between alpha amylase levels
during the day and during the night for the three lighting
conditions showed that the diﬀerence between daytime and
nighttime alpha amylase levels was larger following the
blue light exposure and following the red light exposure
than following the dark condition. The diﬀerence between
daytime alpha amylase levels following blue light exposure
was 35u/ml (P<. 001) and following red light exposure
the diﬀerence was 36u/ml (P = .004) whereas the diﬀerence
between daytime and nighttime amylase levels following the
dark condition was only 24u/ml (P = .04). This analysis
would suggest then that the two light exposures (blue and
red) increased the modulation amplitude of alpha amylase
over 24 hours relative to constant darkness.
4. Discussion
The baseline measurement curves in Figure 2 show that
melatonin, cortisol, and alpha amylase follow circadian
patterns, suggesting that the SCN are involved in their daily
productions, but the present study shows more clearly that
these rhythms have diﬀerent waveforms and diﬀerent phase
relationships with time of day over the course of the 27-hour
study. The results suggest that the HPA and the sympathetic
systems buﬀer one another to maintain homeostasis for
an organism [4]; thus, one might expect counter-phased
circadian rhythms for cortisol and alpha amylase. However,
it is interesting to note that the data in Figure 2 suggest
that the two rhythms are not precisely counter-phased.
Alpha amylase levels peak in the middle of the day and are
lowest during the middle of the night, indicating that the
circadian rhythm of this enzyme is more counter-phased
with melatonin than with the day-night transitional rhythm
of cortisol. Unlike melatonin, however, these results indicate
that alpha amylase varies with a symmetric, cosine-like
waveform over the 24-hour day, rather than the more binary
waveform (high at night and low during the day) rhythm of
melatonin.
Also consistent with previous studies these results show
that the human circadian system is sensitive to 40lx of short-
wavelength (blue) light at the cornea but is not sensitive
to 40lx of long-wavelength (red) light at the cornea as
measured by nocturnal melatonin suppression (Figure 3)
[3, 30–32]; obviously too from the literature, blue light-
induced melatonin suppression is limited to the nighttime
when melatonin levels are high [2]. This replication of many
previously published studies of melatonin rhythms and of
light-induced melatonin suppression supports the validity of
ourexperimentalprotocolforassessingbaselinerhythmsand
for evaluating the eﬀects of acute light exposures on cortisol
and alpha amylase.
Of particular interest with respect to exposures to light
stimuli at night, this study shows, for the ﬁrst time, thatInternational Journal of Endocrinology 7
in contrast to nocturnal melatonin suppression by short-
wavelength light alone, both short-wavelength and long-
wavelength lights aﬀect cortisol levels at night and, although
the eﬀects are weaker, both light exposures appeared to
aﬀect alpha amylase levels as well. Even though both
cortisol and alpha amylase appear to be modulated by both
short-wavelength and long-wavelength lights at night, the
response characteristics of the systems controlling these two
biomarkers are not the same. Cortisol levels are signiﬁcantly
elevated by both the blue and the red lights at night; these
samelightsappeartohaveamuchdiminished eﬀect,ifanyat
all,oncortisollevelsduringtheday.Althoughonlysuggestive
from the present results, light appears to increase the night-
day contrast of the rhythmic alpha amylase pattern over the
24-hour day, suggesting a modulation of sympathetic tone
by light over the course of the 24-hour cycle [23]. In other
words, periodic pulses of light during the day and during
the night appear to increase the diﬀerence between daytime
and nighttime alpha amylase levels. Of signiﬁcance in this
context, since alpha amylase is controlled by the sympathetic
system and since the sympathetic system responds quickly to
environmental stimuli [20], it would be useful to introduce a
higher sampling rate in studies like the present one to better
understand the impact of light on the sympathetic system.
The impacts of narrowband (i.e., blue and red lights)
light exposures on cortisol and alpha amylase levels in
humans have never been reported before. It has been
previously shown in rats, however, that polychromatic, white
light modulates glucocorticoid production, but only if it is
applied at speciﬁc circadian times. Buijs and colleagues [17,
33] showed that white light given in the early part of the dark
phase (ZT 14) in rats will decrease corticosterone production
after 5 minutes of exposure whereas Ishida and colleagues
[11] showed that 60-minute exposures to light at a similar
circadian time will increase corticosterone production. Both
studies showed that light applied later in the subjective
night and during the day had no eﬀect on corticosterone
production in nocturnal animals. As previously noted,
Ishida and colleagues [11] showed that the light-induced
corticosterone increase can be exhibited without aﬀecting
ACTH production; however, the SCN and sympathetic
innervations to the adrenal medulla are necessary for the
nighttime, light-induced activation of corticosterone. Given
the dual control of glucocorticoid production by the HPA
and the sympathetic systems and the temporal dynamics of
these two systems, it is reasonable to infer that the daily
glucocorticoid rhythm is under control of the HPA system
whereas the sympathetic system is responsible for the spike
in glucocorticoid levels just prior to activity. Coming back
to humans and consistent with this dual control hypothesis,
Leproult and colleagues [25] showed that the morning
peak in cortisol was enhanced by as much as 50% by
bright light exposure (above 2000lx at the cornea), but this
enhancing eﬀect was not seen following application of light
in the late afternoon/early evening, when cortisol levels were
relatively lower. Scheer and colleagues also showed an eﬀect
of morning light exposure, but not evening light exposure,
on cortisol levels and on heart rate [24, 26]. The present
results extend those from Scheer and colleagues, by showing
that light exposure during the middle of the night also
increases cortisol production. It should be noted in this
context that, like Scheer and colleagues, “evening” light in
our experiment (at 21:00) did not show any meaningful
light-induced modulation of cortisol. Rather, the signiﬁcant
night-time cortisol response to light was only observed at
01:00 and 05:00.
Clearly then, the light-sensitive mechanisms aﬀecting
nocturnal melatonin suppression are not the same as those
aﬀecting cortisol and apparently not the same as those
aﬀecting alpha amylase. Although the SCN must be involved
in regulating the circadian rhythms of melatonin, cortisol
and alpha amylase, as shown here in Figure 2,i ti sn o t
known whether the photic input acutely modulating these
biomarker levels, as shown here in Figure 3, is independent
of the SCN or whether the SCN response to light is more
complex than presently understood. Of special note, a
previous study by Figueiro and colleagues [30] utilizing a
diﬀerent experimental protocol also showed that both the
blue and the red lights of the same irradiance used in the
present study increased nocturnal alertness as measured
by electroencephalogram (EEG). The present data, and
those by Figueiro and colleagues [30], bring into question
then whether the nonvisual pathway mediating nocturnal
melatonin suppression is the same as that mediating other
nonvisual, photic responses such as the cortisol elevation by
light at night observed in the present study.
In summary, the SCN play a critical role in regulating
the endocrine and autonomic nervous systems. Melatonin,
cortisol, and alpha amylase each exhibit a robust circadian
rhythm under dark conditions across a 24-hour day. These
rhythms appear to diﬀer in their temporal dynamics and
in terms of their response to environmental light presented
at diﬀerent times during the day and night. Of particular
interest with regard to the present study, the photic inputs
to the pineal and to the adrenal glands are clearly diﬀerent;
synthesis of melatonin by the pineal gland is only aﬀected
by short-wavelength light whereas cortisol production by
the adrenal gland is modulated by both short- and long-
wavelength light. It would seem too that the sympathetic
system response, as measured in terms of alpha amylase
concentration, also has a spectral sensitivity to light broader
than that leading to the pineal gland response. It remains
to be determined whether the suggested broader spectral
sensitivity of the alpha amylase response is the same as that
leading to the light-induced cortisol response by the adrenal
gland. Nevertheless, the present results clearly demonstrate
that a photic pathway to the endocrine and autonomic ner-
vous systems exists other than that responsible for nocturnal
melatonin suppression.
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